chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On unspecified dates in 2014 (reported as "about three years ago"), the patient was vaccinated with the first and second doses of GARDASIL (strength, dose, route of administration, lot number and expiration date were unknown) for prophylaxis. On 17-FEB-2017 (reported as "currently"), the patient was in the office to receive a third dose of the human papillomavirus (HPV) series in which GARDASIL 9 (strength, dose, route of administration, lot number and expiration date were unknown) would be administered for the same indication. No adverse effect was reported. Additional information has been requested.
feeling dizziness; allergy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feeling dizziness) and HYPERSENSITIVITY (allergy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (feeling dizziness) and HYPERSENSITIVITY (allergy). At the time of the report, DIZZINESS (feeling dizziness) and HYPERSENSITIVITY (allergy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication use was provided by the reporter.  No treatment of events was reported.
Redness, sore, and pain at the inject site and spread to under arm. No fever, but increased tiredness.
Pt had first Moderna Covid vaccine (015M20A) 3 weeks on 2/14/21 ago and second one last Sunday 3/14/21 (024M20A).    Initial vaccine - reports an immediate HA prior to sitting down for 15 min post injection waiting period as well as arm redness, and abd pain that felt like "spastic colon or diverticulitis" with pain and diarrhea. Does not have these medical conditions.   2nd vaccine - Again developed immediate HA, arm redness that was worse, fatigue, myalgia, fever Tmax 100.4. Yesterday she was at store and got dizzy, developed back pain, then rash, and then bladder, frequent urination, and dysuria. )
Rash, upset stomach (gassy and diaherria), headache, back ache,tired, very irratiable at school and the teacher complained.
Pt developed Myocardial infarction and MI a week after administration of Anthrax vaccination. Pt did not have any coronary risk factors (no family history of CAD/MI, No HTN, No HLP). Pt is healthy and active. 1/27/09-records received-Acute myocardial infarction.
Disequilibrium, very mild; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3249), via an unspecified route of administration in the right arm on 13Jan2021 08:30 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced disequilibrium, very mild on 13Jan2021 09:00. No treatment was received for the event. Outcome of the event was recovering.
dizzy; This is a spontaneous report from a contactable consumer. A 70-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 21Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient woke up on 22Jan2021 and was feeling dizzy. She was asking if that was normal. Outcome of the event was unknown.  Information on lot/batch number has been requested.
1 1/2 hrs p/vax swelling of lt leg, swelling of eyelids, lips w/wheezing;
I cough all the time; Headache/persisting headache; Fever; Cold like in my bones, I feel chills.; Cold like in my bones, I feel chills.; Breathing has been acting up; shortness of breath; Body ache; This is a spontaneous report from a contactable consumer (patient) reported for self. A 38-years-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0185, Expiration Date: unknown) via an unspecified route of administration, administered in arm on 09May2021 around 8.30 to 9:00 am (age at vaccination was 38 years) as 2nd dose, single dose for COVID-19 immunization. The patient did not have any medical history. Concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0162, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 18Apr2021 around 13:00 pm (age at vaccination was 38 years) as 1st dose, single dose for COVID-19 immunization. The patient took the COVID Vaccine for prevention from COVID. The patient stated that the patient got COVID Vaccine on 09May2021, second shot but then after 2-3 days after the patient had been having reactions to it. The patient went to the doctor and she told to make sure to call and report the symptoms. On 14May2021, the patient experienced headache, fever, cold like in patient's bones, felt chills, breathing had been acting up, shortness of breath and body ache. Because the symptoms the patient was having were persisting headache and cold and patient's breathing had been acting up and patient cough all the time. The patient also had body ache. The body ache went away but shortening of breath and headache patient still had. She told the patient to call Pfizer to report the symptoms. The patient was informed the role of Pfizer Drug Safety. The patient confirmed started experiencing the event after the second dose. The patient stated that when the patient went to the doctor, she did the blood work and sent the patient for a chest X-ray for breathing and the result was unknown. The patient did not know the name of test. The patient stated that the patient was still experiencing the headache and the cold like in patient's bones, the patient felt chills. The fever, it came and went but it was not as bad as it was before. It was improved. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient stated that doctor prescribed antibiotics and also gave the patient a nebulizer to take albuterol treatment for breathing. The outcome of the event fever was resolving. The outcome of the events headache/persisting headache, cold like in my bones, I feel chills and breathing has been acting up, shortness of breath was not resolved. The outcome of the event body ache was resolved on an unknown date in 2021. The outcome of the event I cough all the time was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Right sided supraclavicular lymph node enlargement and pain; Right sided supraclavicular lymph node enlargement and pain; This is a spontaneous report from a contactable nurse reporting for herself. A 40-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) (lot# EJI1686), intramuscular in right arm, on 29Dec2020, at single dose, for COVID-19 immunisation. The patient's medical history was not reported. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included celecoxib (CELEXA), vitamin d [vitamin d nos] (unknown manufacturer), post natal vitamin. No any other vaccine within 4 weeks prior to the COVID vaccine was administered. The patient previously took butorphanol tartrate (STADOL) and experienced drug hypersensitivity. The patient experienced right sided supraclavicular lymph node enlargement and pain on an unspecified date with outcome of recovering. No treatment was given. The patient has not been tested for COVID-19 since the vaccination.
cool skin yet sweating, dizzy, general weakness, loose stools, migraine h/a, pale skin, severe nausea, skin hurt;
Pt. given vaccine at 1600 on 11/16/10. Seemed fine that eve. Woke at 0400 with fever, mom gave 1 1/2 tsp. MOTRIN & went back to sleep in mom's bed. Mom woke at 0645 to child's left arm jerking and "out of it". Mom called 911, seizure lasted 10-15 min. Transported to ER.
May91 rash& polyarthralgia;polyarthralgia worsened w/ hand swelling & saw MD 26jun91;25jul91 ANA & RF neg;14feb92 polyarthralgia persisted w/ warmth & swelling of knees;the polyarthralgia persisted on 13jun93;
Information has been reported in a published article concerning a young women who were vaccinated with a dose of GARDASIL and approximately 1 month later presented to clinics with a demyelinating syndrome that subsequently met criteria for multiple sclerosis. At the time of report the outcome was unknown. The reporter felt that aggressive acute disseminated encephalomyelitis was related to therapy with GARDASIL. Upon internal review, multiple sclerosis was determined to be an other important medical event. This is one of several reports from the same source. Additional information has been requested.
Puffiness on left side above waist (armpit, face); Headache; Injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6205), via an unspecified route of administration on the left arm on 01Mar2021 at 08:15 (at the age of 62-year-old), as a first single dose for COVID-19 immunisation. Medical history included atrial fibrillation and other heart concerns. Concomitant medication included mtroplol (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), furosemide (MANUFACTURER UNKNOWN), Lsrtn (MANUFACTURER UNKNOWN), Xrlto (MANUFACTURER UNKNOWN), Actomnphn (MANUFACTURER UNKNOWN). The patient did not know whether had any known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 01Mar2021 at 08:15, the patient experienced headache, very minor puffiness on left side above waist (armpit, face), extremely minors injection site soreness only if touched the next day. The patient also reported that headache and puffiness were gone next morning and soreness did not even last the entire day following injection. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, puffiness on left side above waist (armpit, face) was resolved on 02Mar2021 and injection site soreness was resolved on an 01Mar2021at the time of this report.    No follow-up attempts are needed. No further information is expected.
Narrative:  Patient recently established care with clinic in August 2022. During initial PCP visit on 8/24/22, an allergy assessment was performed and patient reported experiencing urticaria after receiving the Twinrix vaccine. this adverse reaction was documented in system at this time. Per chart, patient received at lead 3 doses of Twinrix hepatitis A/B vaccine series outside of the clinic from an unknown provider. These dates were 5/21/2007 (dose 1), 2/28/2008 (dose 2), and 6/16/2010 (dose 3). It is unclear whether the reaction took place with all vaccines within series, or just one. It is unclear whether additional medical interventions were necessary,
PATIENT RECEIVED FLUBLOK QUAD VACCINE ON 11/10/21. PATIENT CAME TO PHARMACY ON 11/11/21 REPORTING SWELLING AND REDNESS AT INJECTION SITE. PATIENT REPORTS NO OTHER SYMPTOMS AND WANTED ADVISE AS WHAT TO DO. ADVISED PATIENT TO CALL DOCTOR SO THEY ARE AWARE OF REACTION, TOLD PATIENT I WOULD REPORT HERE AT THE PHARMACY. ALSO TOLD PATIENT CAN TAKE OVER THE COUNTER NSAID AND ICE AREA TO HELP SWELLING AND PAIN. ADVISED PATIENT TO GO TO EMERGENCY ROOM IF RASH CONTINUES TO SPREAD OR IF SHE HAS TROUBLE BREATHING. PATIENT SAID SHE WOULD CALL DOCTOR ON 11/12/21.
Client received the 1st dose of the COVID vaccine (Pfizer Lot #EW0186 expiration date 07/12/2021) at 1309. At 1326, the client called EMT over and said "I'm having itching and something in my chest." PHN responded. The client stated, "I'm not having any trouble breathing or any swelling. When I breathe in, I feel something in my chest. It comes and goes. I have itching in my left palm but its already going away." Client was alert and oriented times four. EMT and PHN escorted the client to the zero gravity chair. Vital signs taken at 1329 (blood pressure 130/60, heart rate 83, oxygen 97%). At 1330, PHN offered the client Benadryl which he refused and stated, "I don't feel the itchiness anymore." Client stated, "I don't like needles. I was nervous about getting the vaccine." Client denies any medical conditions and allergies. The client is taking Zyrtec and prescription eye drops. At 1338, client stated, "I haven't felt the feeling in my chest since we moved over here." Vital signs taken at 1340 (blood pressure 132/78, heart rate 76, oxygen 96%). At 1345, the client stated, "my chest feels fine." Vital signs taken at 1351 (blood pressure 130/74, heart rate 82, oxygen 97%). PHN provided client with education on when to seek emergency services, and to follow up with his primary care provider. Client left unassisted with a steady gait at 1356.
Information has been received from the patient's mother via internet. The mother stated that her 16 year old daughter was injured by GARDASIL. On 09-JAN-2009, the patient was vaccinated with the first dose of GARDASIL and on 09-MAR-2008 with the second dose of GARDASIL. Before GARDASIL, she was happy, healthy and vibrant teenager. Since GARDASIL, the patient was sick every day of her life. She had dizziness, overall weakness, numbness and tingling in both legs and left arm, back pain, neck pain, pressure headaches, vision problems, breathing problems, chest pains, racing heartbeats, brain fog, stomach problems, nausea, diarrhea, weight loss, hair loss, jerking all over spells, the list goes on. She was and a/B student but failed her 10th grade year because she was too sick to retain what she was trying to learn (brain fog). she was no longer had energy to go off with her friends. Most days she lays in bed, in pain. The patient had been in the emergency room twice, once by ambulance for stopping breathing 3 times. She was seen several doctors. She had CT scan done. All tests come back normal (which is typical with all of the injured GARDASIL vaccine girls). Her blood panel showed high on immunoglobulin E (131H) and Anti streptolysin O (208H) which the doctor "thought" was rheumatic fever. Another doctor had said he did not believe she had rheumatic fever. Brain fog and energy increased were considered to be disability. This is one of several reports provided by the same source. No further information is available.
patient was administered from an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was administered from an expired vaccine) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was administered from an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was administered from an expired vaccine) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   2 vials from same lot number 1st vial Lot number: 050E21A , administered on 05-Nov-2021 2nd vial Lot number: 050E21A, administered on 12-Nov-2021. No concomitant medication was provided by the reporter. 34 patients were administered from an expired vaccine. 16 staff members were administered from the expired vaccine. 2 patients have passed  away. No treatment was provided by the reporter.
22JAN started to have gen body, malaise;25JAN body malaise became worse w/fever;27JAN body malaise more severe, fever & devel red spots arms, thighs, back, chest & abd area;
Sore arm; chills; Fever; Extreme headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), CHILLS (chills), PYREXIA (Fever) and HEADACHE (Extreme headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced PAIN (Body aches), CHILLS (chills) and HEADACHE (Extreme headache). 08-Apr-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), CHILLS (chills), PYREXIA (Fever) and HEADACHE (Extreme headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medicines was not reported by reporter   treatment information was not provided   The action taken with mRNA-1273 with the events was considered as not applicable     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to US-MODERNATX, INC.-MOD-2021-072968 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-072968:
Difficulty breathing, shallow and rapid breathing, Diminished lung sounds, skin warm to touch. 50mg Benadryl at 0921 and 0.3mg Epi at 0914.
Left deltoid red, swollen & warm to touch. Also with firmness. Ibuprofen 300mg was given at 9:20AM, and applied ice to site. Erythema and firmness is on anterior upper arm extending over half the upper arm. Nothing posteriorly.
8MAR91 fever 103 ax, redness @ inject site, fussiness, loss of appetite, vomiting, convuls on 11MAR91;
dISCHARGE SUMMARY " Admitting Diagnosis: IUP at 39+ wks, Breech presentation, COVID+, religious preference - declines blood products   Reasons for Admission:  Scheduled C/S   Prenatal Procedures: U/S x 3   Intrapartum Procedures: PLTCS   Postpartum Procedures: None   Postpartum/Operative Complications: None   Newborn Data: Female   Discharge Diagnosis: Term Pregnancy-Delivered COVID+"
Low-grade fever and fatigue, followed by increased fever and chills.  Nausea & diarrhea.  Severe headache.  All symptoms continued throughout the night.  Severe headache persisted until following day.  Ibuprofen taken to relieve headache.  All symptoms were diminished by that time.
24 hours post vaccination patient with throat tightening and shortness of breath. Patient self treated using her asthma inhaler
prone to sinus infections; Tested positive for COVID; This is a spontaneous report from a contactable Nurse. A 67-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EL9262), dose 1 via an unspecified route of administration, administered in left deltoid on 08feb2021 at 3:15 PM as single dose for covid-19 immunisation. Medical history included sinusitis, diverticulitis. Concomitant medication(s) included levothyroxine sodium (LEVOXYL) taken for thyroid disorder, docusate sodium (COLACE) taken for diverticulitis; calcium carbonate, Vitamin D 2000 units, colecalciferol (vitamin d 2000). Her husband started not feeling well 1.5 weeks post vaccination. She specified her husband was also sneezing and she didn't have symptoms beside maybe a sinus congestion when waking up in the morning, which she has regularly. She said they are both prone to sinus infections (non serious), and her husband had a "sinus infection" with a "negative covid-19 test back in november. Due to having contact with her husband who had tested positive for COVID she also got tested for COVID. She mentioned she only goes out walking 3-4 miles each day, or bicycle 6-7 miles a day in the gym downstairs in their apartment complex. She has no symptoms whatsoever. She was not sleeping a lot with her husband because he was already in a different room due to his sleeping habits. She had a rapid COVID test done on 20Feb2021 and it was negative. On Saturday at the Urgent care she asked were the Rapid PCR test could be done. The rapid test was done via nasal swab. She had an oral COVID test done yesterday 21Feb2021 and it was positive. She has not had the second dose of the vaccine yet. The event assessed as medically significant. The outcome of the events was unknown.; Sender's Comments: Based on the temporal relationship, A possible contributory role of the suspect product to the development of Sinusitis cannot be excluded.,Linked Report(s) : US-PFIZER INC-2021218654 same reporter/drug, similar event, different patient
1/19/2021 7PM  UNTIL 1PM 1/20: HEADACHE, CHILLS, LOW GRADE FEVER (100.9), BODY ACHES, SIGNIFICANT SORENESS AT INJECTION SITE. TOOK TYLENOL 7AM 1/20.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. No medical history and concurrent conditions were reported. On an unknown date the patients were vaccinated with a dose of improperly stored VARIVAX (lot number L046884, expiry date 23-NOV-2017) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse effects were reported. It was reported that the VARIVAX was exposed to a temperature of 19.1 degrees Fahrenheit for 156 hours. There was no previous temperature excursions. It was reported that this case was reported due to a data logger. The action taken with the therapy with VARIVAX was unknown. The outcome of events was unknown. There was no product quality complaint reported. This case is related case number US-009507513-1606USA005776 via same reporter link. Additional information has been requested.
Case number PHEH2013US024301, is an initial spontaneous report received from a nurse on 18 NOV 2013. This case refers to a female patient of unknown age. Past medical history and concomitant medication were not reported.  She was vaccinated with expired  FLUVIRIN 2013/2014 (batch number: 1207101 expiry date: JUN 2013) at a dose of 0.5 ml intramuscularly on 15 NOV 2013. No adverse event was reported following this administration error.
The staff member received a Pfizer vaccine booster 1 hour and 8 minutes past the expiration time. No symptoms reported at this time
Two days after my vaccinations for each dose I experienced some sinus problems. The sinus issues made my nose extremely itches and strong hard sneezes. I experienced fatigue for 4 days straight after my 2nd dose and my booster shot. I was extremely tired to the point I was not able to operate a mobile vehicle. I have since recovered from the fatigue but the strong hard sneezing and constant itching of the nose continues.
Parent of child wrote the wrong birthday on the consent form. Parent wrote 5/2/2009 but the patient's real birthday is 5/2/2010, meaning that the patient was 11 year old when the patient received a 12+ pfizer shot. I called the parent and confirmed the birthday of 5/2/2010 and informed the parent that a VAERS will be reported.
Pt vomited w/in 1 hr of receiving vax, t105, mild diarrhea; Seen by MD;